219 related articles for article (PubMed ID: 36999187)
1. Blood-brain Barrier and Neurovascular Unit Dysfunction in Parkinson's Disease: From Clinical Insights to Pathogenic Mechanisms and Novel Therapeutic Approaches.
Khor SLQ; Ng KY; Koh RY; Chye SM
CNS Neurol Disord Drug Targets; 2024; 23(3):315-330. PubMed ID: 36999187
[TBL] [Abstract][Full Text] [Related]
2. Blood-brain barrier pathology in Alzheimer's and Parkinson's disease: implications for drug therapy.
Desai BS; Monahan AJ; Carvey PM; Hendey B
Cell Transplant; 2007; 16(3):285-99. PubMed ID: 17503739
[TBL] [Abstract][Full Text] [Related]
3. Blood-Brain Barrier Dysfunction in CNS Disorders and Putative Therapeutic Targets: An Overview.
Archie SR; Al Shoyaib A; Cucullo L
Pharmaceutics; 2021 Oct; 13(11):. PubMed ID: 34834200
[TBL] [Abstract][Full Text] [Related]
4. Factors influencing the blood-brain barrier permeability.
Zhao Y; Gan L; Ren L; Lin Y; Ma C; Lin X
Brain Res; 2022 Aug; 1788():147937. PubMed ID: 35568085
[TBL] [Abstract][Full Text] [Related]
5. New Blood-Brain Barrier Models Using Primary Parkinson's Disease Rat Brain Endothelial Cells and Astrocytes for the Development of Central Nervous System Drug Delivery Systems.
Cai P; Zheng Y; Sun Y; Zhang C; Zhang Q; Liu Q
ACS Chem Neurosci; 2021 Oct; 12(20):3829-3837. PubMed ID: 34623131
[TBL] [Abstract][Full Text] [Related]
6. A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity.
Kadry H; Noorani B; Cucullo L
Fluids Barriers CNS; 2020 Nov; 17(1):69. PubMed ID: 33208141
[TBL] [Abstract][Full Text] [Related]
7. Blood-brain barrier: structural components and function under physiologic and pathologic conditions.
Persidsky Y; Ramirez SH; Haorah J; Kanmogne GD
J Neuroimmune Pharmacol; 2006 Sep; 1(3):223-36. PubMed ID: 18040800
[TBL] [Abstract][Full Text] [Related]
8. Astrocytic modulation of blood brain barrier: perspectives on Parkinson's disease.
Cabezas R; Avila M; Gonzalez J; El-Bachá RS; Báez E; García-Segura LM; Jurado Coronel JC; Capani F; Cardona-Gomez GP; Barreto GE
Front Cell Neurosci; 2014; 8():211. PubMed ID: 25136294
[TBL] [Abstract][Full Text] [Related]
9. ABC transporters and drug efflux at the blood-brain barrier.
Shen S; Zhang W
Rev Neurosci; 2010; 21(1):29-53. PubMed ID: 20458886
[TBL] [Abstract][Full Text] [Related]
10. The blood-brain barrier.
Obermeier B; Verma A; Ransohoff RM
Handb Clin Neurol; 2016; 133():39-59. PubMed ID: 27112670
[TBL] [Abstract][Full Text] [Related]
11. Blood-brain barrier integrity in the pathogenesis of Alzheimer's disease.
Huang Z; Wong LW; Su Y; Huang X; Wang N; Chen H; Yi C
Front Neuroendocrinol; 2020 Oct; 59():100857. PubMed ID: 32781194
[TBL] [Abstract][Full Text] [Related]
12. Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease.
Yamazaki Y; Kanekiyo T
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28902142
[TBL] [Abstract][Full Text] [Related]
13. Targetability of the neurovascular unit in inflammatory diseases of the central nervous system.
Smith BC; Tinkey RA; Shaw BC; Williams JL
Immunol Rev; 2022 Oct; 311(1):39-49. PubMed ID: 35909222
[TBL] [Abstract][Full Text] [Related]
14. Structure and Function of the Blood-Brain Barrier (BBB).
Benz F; Liebner S
Handb Exp Pharmacol; 2022; 273():3-31. PubMed ID: 33249527
[TBL] [Abstract][Full Text] [Related]
15. The contribution of inflammatory astrocytes to BBB impairments in a brain-chip model of Parkinson's disease.
de Rus Jacquet A; Alpaugh M; Denis HL; Tancredi JL; Boutin M; Decaestecker J; Beauparlant C; Herrmann L; Saint-Pierre M; Parent M; Droit A; Breton S; Cicchetti F
Nat Commun; 2023 Jun; 14(1):3651. PubMed ID: 37339976
[TBL] [Abstract][Full Text] [Related]
16. The blood-brain barrier in Alzheimer's disease.
Zenaro E; Piacentino G; Constantin G
Neurobiol Dis; 2017 Nov; 107():41-56. PubMed ID: 27425887
[TBL] [Abstract][Full Text] [Related]
17. Profiling the neurovascular unit unveils detrimental effects of osteopontin on the blood-brain barrier in acute ischemic stroke.
Spitzer D; Guérit S; Puetz T; Khel MI; Armbrust M; Dunst M; Macas J; Zinke J; Devraj G; Jia X; Croll F; Sommer K; Filipski K; Freiman TM; Looso M; Günther S; Di Tacchio M; Plate KH; Reiss Y; Liebner S; Harter PN; Devraj K
Acta Neuropathol; 2022 Aug; 144(2):305-337. PubMed ID: 35752654
[TBL] [Abstract][Full Text] [Related]
18. Development of Novel Therapeutics Targeting the Blood-Brain Barrier: From Barrier to Carrier.
Li J; Zheng M; Shimoni O; Banks WA; Bush AI; Gamble JR; Shi B
Adv Sci (Weinh); 2021 Aug; 8(16):e2101090. PubMed ID: 34085418
[TBL] [Abstract][Full Text] [Related]
19. Blood-Brain Barrier: From Physiology to Disease and Back.
Sweeney MD; Zhao Z; Montagne A; Nelson AR; Zlokovic BV
Physiol Rev; 2019 Jan; 99(1):21-78. PubMed ID: 30280653
[TBL] [Abstract][Full Text] [Related]
20. Dysfunction of the Neurovascular Unit by Psychostimulant Drugs.
Vo TTL; Shin D; Ha E; Seo JH
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
